Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Arrowhead initiated with an Outperform at RBC Capital » 16:18
05/12/20
05/12
16:18
05/12/20
16:18
ARWR

Arrowhead

$35.91 /

-0.41 (-1.13%)

RBC Capital analyst Luca…

RBC Capital analyst Luca Issi initiated coverage of Arrowhead with an Outperform rating and $62 price target. The company has a potential first-in-class treatment with A1AT while APOC3/ANG3 are promising CV targets with superior profiles, Issi tells investors.

ShowHide Related Items >><<
ARWR Arrowhead
$35.91 /

-0.41 (-1.13%)

ARWR Arrowhead
$35.91 /

-0.41 (-1.13%)

05/11/20 B. Riley FBR
Arrowhead attractively valued after recent pullback, says B. Riley FBR
05/08/20 Oppenheimer
Arrowhead upgraded to Outperform from Perform at Oppenheimer
05/08/20 Oppenheimer
Arrowhead upgraded to Outperform from Perform at Oppenheimer
04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
ARWR Arrowhead
$35.91 /

-0.41 (-1.13%)

ARWR Arrowhead
$35.91 /

-0.41 (-1.13%)

ARWR Arrowhead
$35.91 /

-0.41 (-1.13%)

Recommendations
Arrowhead attractively valued after recent pullback, says B. Riley FBR » 08:34
05/11/20
05/11
08:34
05/11/20
08:34
ARWR

Arrowhead

$34.24 /

-0.91 (-2.59%)

B. Riley FBR analyst…

B. Riley FBR analyst Mayank Mamtani continues to find Arrowhead Pharmaceuticals shares attractively valued, especially given the recent pullback. With $498.2M of cash, the company has the balance sheet to support "multi-year runway for a growing pipeline across multiple therapeutic areas," Mamtani tells investors in a research note. The analyst reiterates a Buy rating on the shares with a $57 price target.

ShowHide Related Items >><<
ARWR Arrowhead
$34.24 /

-0.91 (-2.59%)

05/08/20 Oppenheimer
Arrowhead upgraded to Outperform from Perform at Oppenheimer
05/08/20 Oppenheimer
Arrowhead upgraded to Outperform from Perform at Oppenheimer
04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
Upgrade
Arrowhead upgraded to Outperform from Perform at Oppenheimer » 09:26
05/08/20
05/08
09:26
05/08/20
09:26
ARWR

Arrowhead

$35.15 /

+0.98 (+2.87%)

Oppenheimer analyst…

Oppenheimer analyst Esther Rajavelu upgraded Arrowhead to Outperform from Perform with a $58 price target following the company's Q2 results and business update that increased her confidence that timing for ARO-AAT open-label Cohort-1 data remains intact despite COVID-19 related operational delays. The analyst believes the next 12-18 months may offer opportunities to assess clinical evidence of TRiM applicability beyond hepatocytes.

ShowHide Related Items >><<
ARWR Arrowhead
$35.15 /

+0.98 (+2.87%)

05/08/20 Oppenheimer
Arrowhead upgraded to Outperform from Perform at Oppenheimer
04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
Upgrade
Arrowhead upgraded to Outperform from Perform at Oppenheimer » 06:46
05/08/20
05/08
06:46
05/08/20
06:46
ARWR

Arrowhead

$35.15 /

+0.98 (+2.87%)

Oppenheimer analyst…

Oppenheimer analyst Esther Rajavelu upgraded Arrowhead to Outperform from Perform with a $58 price target.

ShowHide Related Items >><<
ARWR Arrowhead
$35.15 /

+0.98 (+2.87%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
On The Fly
Fly Intel: After-Hours Movers » 19:21
05/07/20
05/07
19:21
05/07/20
19:21
INTU

Intuit

$280.75 /

+4.9 (+1.78%)

, YELP

Yelp

$22.89 /

+0.74 (+3.34%)

, PCTY

Paylocity

$121.41 /

+6.7 (+5.84%)

, MDRX

Allscripts

$5.87 /

+0.36 (+6.53%)

, OLED

Universal Display

$156.23 /

+9.9 (+6.77%)

, CTSH

Cognizant

$58.81 /

+1.16 (+2.01%)

, SWIR

Sierra Wireless

$9.21 /

-0.24 (-2.54%)

, TRIP

TripAdvisor

$18.71 /

+0.63 (+3.48%)

, FISV

Fiserv

$107.42 /

+1.96 (+1.86%)

, ACAD

Acadia

$49.17 /

+1.07 (+2.22%)

, STMP

Stamps.com

$194.80 /

+10.02 (+5.42%)

, TTD

Trade Desk

$322.98 /

+10.62 (+3.40%)

, MSI

Motorola Solutions

$135.54 /

+0.19 (+0.14%)

, ROKU

Roku

$137.73 /

+10.26 (+8.05%)

, TDC

Teradata

$23.66 /

+0.73 (+3.18%)

, QLYS

Qualys

$111.51 /

+5.94 (+5.63%)

, LOPE

Grand Canyon

$87.96 /

+1.71 (+1.98%)

, APPN

Appian

$53.25 /

+3.82 (+7.73%)

, AVID

Avid Technology

$6.30 /

+0.28 (+4.65%)

, NET

Cloudflare

$29.48 /

+4.52 (+18.11%)

, HEAR

Turtle Beach

$11.48 /

+1.18 (+11.46%)

, TRUE

TrueCar

$3.34 /

+0.34 (+11.33%)

, ARWR

Arrowhead

$35.15 /

+0.98 (+2.87%)

, SVMK

SurveyMonkey

$17.02 /

+1.11 (+6.98%)

, GLUU

Glu Mobile

$8.94 /

+0.21 (+2.41%)

, DBX

Dropbox

$21.90 /

+1.55 (+7.62%)

, SAIL

SailPoint

$19.84 /

+0.82 (+4.31%)

, UBER

Uber

$30.90 /

+3.06 (+10.99%)

, GPRO

GoPro

$3.35 /

+0.105 (+3.24%)

, XNCR

Xencor

$30.04 /

-0.95 (-3.07%)

, KTOS

Kratos Defense

$14.98 /

+0.12 (+0.81%)

, GH

Guardant Health

$84.06 /

+3.06 (+3.78%)

, IPHI

Inphi

$98.85 /

+2.46 (+2.55%)

, AAXN

Axon

$70.25 /

+4.14 (+6.26%)

, SPWR

SunPower

$7.26 /

-0.25 (-3.33%)

, SKYW

SkyWest

$24.05 /

+0.03 (+0.12%)

, HLF

Herbalife Nutrition

$36.93 /

+3.12 (+9.23%)

, PAR

Par Technology

$19.73 /

+1 (+5.34%)

, CWH

Camping World

$10.77 /

+0.39 (+3.76%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
INTU Intuit
$280.75 /

+4.9 (+1.78%)

05/05/20 KeyBanc
Intuit price target raised to $285 from $275 at KeyBanc
04/17/20 RBC Capital
Intuit lowered to $280 from $345 at RBC Capital
04/13/20 Jefferies
Jefferies continues to like Intuit after approval for small business lending
04/07/20 Citi
Intuit price target lowered to $272 from $312 at Citi
YELP Yelp
$22.89 /

+0.74 (+3.34%)

04/13/20 DA Davidson
Yelp price target lowered to $26 from $48 at DA Davidson
04/13/20 SunTrust
Yelp price target lowered to $22 from $37 at SunTrust
04/09/20 SunTrust
Yelp price target lowered to $22 from $37 at SunTrust
04/09/20 Baird
Yelp price target lowered to $22 from $30 at Baird
PCTY Paylocity
$121.41 /

+6.7 (+5.84%)

04/16/20
Fly Intel: Top five analyst downgrades
04/16/20 Stifel
Paylocity downgraded to Hold from Buy at Stifel
04/15/20 Stifel
Paylocity downgraded to Hold from Buy at Stifel
03/27/20 SunTrust
Paylocity price target lowered to $115 from $162 at SunTrust
MDRX Allscripts
$5.87 /

+0.36 (+6.53%)

04/22/20 Jefferies
Allscripts downgraded to Hold due to pressure on customers at Jefferies
04/22/20 Jefferies
Allscripts downgraded to Hold from Buy at Jefferies
04/20/20 RBC Capital
Allscripts initiated with an Outperform at RBC Capital
04/13/20 SVB Leerink
Allscripts initiated with a Market Perform at SVB Leerink
OLED Universal Display
$156.23 /

+9.9 (+6.77%)

05/04/20 Cowen
Universal Display upgraded to Outperform at Cowen
05/04/20 Cowen
Universal Display upgraded to Outperform from Market Perform at Cowen
02/24/20 Roth Capital
Universal Display price target lowered to $182 from $216 at Roth Capital
11/22/19
Fly Intel: Top five analyst downgrades
CTSH Cognizant
$58.81 /

+1.16 (+2.01%)

05/04/20
Fly Intel: Top five analyst downgrades
05/04/20 BMO Capital
Cognizant downgraded to Market Perform from Outperform at BMO Capital
04/14/20 Wells Fargo
Cognizant price target lowered to $60 from $76 at Wells Fargo
04/13/20 Baird
Cognizant price target raised to $60 from $50 at Baird
SWIR Sierra Wireless
$9.21 /

-0.24 (-2.54%)

02/14/20 Roth Capital
Roth Capital sees upside in Sierra Wireless after 2020 transition year
11/06/19 Raymond James
Sierra Wireless downgraded to Market Perform from Outperform at Raymond James
11/06/19 RBC Capital
Sierra Wireless price target lowered to $12 from $14 at RBC Capital
TRIP TripAdvisor
$18.71 /

+0.63 (+3.48%)

05/06/20
Fly Intel: Top five analyst downgrades
05/06/20 Cleveland Research
TripAdvisor checks remain 'quite cautious,' says Cleveland Research
05/06/20 Deutsche Bank
Deutsche downgrades TripAdvisor on lack of confidence in travel rebound
05/06/20 Deutsche Bank
TripAdvisor downgraded to Hold from Buy at Deutsche Bank
FISV Fiserv
$107.42 /

+1.96 (+1.86%)

04/13/20 Raymond James
Fiserv price target lowered to $108 from $133 at Raymond James
04/09/20 Stephens
Stephens says new Fed actions most positive for Square, Global Payments, PayPal
04/08/20 Wells Fargo
Fiserv price target lowered to $110 from $146 at Wells Fargo
03/27/20 JPMorgan
FIS, Fiserv upgraded to Overweight from Neutral at JPMorgan
ACAD Acadia
$49.17 /

+1.07 (+2.22%)

04/16/20
Fly Intel: Top five analyst initiations
04/16/20 Jefferies
Acadia initiated with a Buy at Jefferies
04/03/20 Piper Sandler
Acadia one of the safer names to own right now, says Piper Sandler
03/31/20 Goldman Sachs
Acadia upgraded to Buy from Neutral at Goldman Sachs
STMP Stamps.com
$194.80 /

+10.02 (+5.42%)

04/29/20
Fly Intel: Top five analyst upgrades
04/29/20 Craig-Hallum
Stamps.com price target raised to $200 from $150 at Craig-Hallum
04/29/20 Northland
Stamps.com upgraded to Outperform from Market Perform at Northland
04/09/20 Craig-Hallum
Stamps.com to benefit from Amazon exiting Shipping service, says Craig-Hallum
TTD Trade Desk
$322.98 /

+10.62 (+3.40%)

05/05/20 SunTrust
Trade Desk price target lowered to $280 from $305 at SunTrust
05/05/20 Oppenheimer
Trade Desk price target raised to $300 from $230 at Oppenheimer
04/15/20 Pivotal Research
Trade Desk price target lowered to $267 from $320 at Pivotal Research
04/02/20 Rosenblatt
Rosenblatt cuts advertising estimates, says Facebook/Roku/Snap show best upside
MSI Motorola Solutions
$135.54 /

+0.19 (+0.14%)

03/26/20 Northcoast
Motorola Solutions upgraded to Buy from Neutral at Northcoast
03/03/20 JPMorgan
Motorola Solutions upgraded to Neutral on valuation at JPMorgan
03/03/20 JPMorgan
Motorola Solutions upgraded to Neutral from Underweight at JPMorgan
02/10/20 MKM Partners
Motorola Solutions price target raised to $192 from $167 at MKM Partners
ROKU Roku
$137.73 /

+10.26 (+8.05%)

04/29/20
Fly Intel: Top five analyst initiations
04/29/20 Benchmark
Benchmark starts 'long-term winner' Roku at Buy
04/29/20 Benchmark
Roku initiated with a Buy at Benchmark
04/28/20
Fly Intel: Top five analyst downgrades
TDC Teradata
$23.66 /

+0.73 (+3.18%)

04/02/20 Citi
Teradata upgraded to Buy from Sell at Citi
02/10/20 BMO Capital
Teradata price target lowered to $27 from $30 at BMO Capital
11/20/19 Gordon Haskett
Teradata interim CEO eligible for change in control plan, says Gordon Haskett
11/11/19 BMO Capital
Teradata price target lowered to $30 from $38 at BMO Capital
QLYS Qualys
$111.51 /

+5.94 (+5.63%)

05/01/20 Monness Crespi
Qualys downgraded to Neutral following outperformance at Monness Crespi
05/01/20 Monness Crespi
Qualys downgraded to Neutral from Buy at Monness Crespi
04/27/20 JMP Securities
Qualys downgraded to Market Perform from Outperform at JMP Securities
04/27/20 JMP Securities
Qualys downgraded to Market Perform from Outperform at JMP Securities
LOPE Grand Canyon
$87.96 /

+1.71 (+1.98%)

04/21/20 BMO Capital
Grand Canyon price target lowered to $95 from $106 at BMO Capital
04/15/20 Barrington
Grand Canyon price target lowered to $110 from $125 at Barrington
03/16/20 Baird
Grand Canyon transition to online shows hybrid model strength, says Baird
02/20/20 Baird
Grand Canyon valuation highly attractive, says Baird
APPN Appian
$53.25 /

+3.82 (+7.73%)

04/14/20 Morgan Stanley
Appian downgraded to Underweight on near-term challenges at Morgan Stanley
04/14/20 Morgan Stanley
Appian downgraded to Underweight from Equal Weight at Morgan Stanley
02/19/20 Needham
Appian downgraded to Hold from Buy at Needham
02/19/20 Needham
Appian downgraded to Hold from Buy at Needham
AVID Avid Technology
$6.30 /

+0.28 (+4.65%)

04/08/20 Jefferies
Avid Technology recurring business 'holding up,' says Jefferies
11/15/19 B. Riley FBR
Avid Technology initiated with a Buy at B. Riley FBR
06/07/19 Jefferies
Avid Technology price target raised to $8.50 from $6.50 at Jefferies
NET Cloudflare
$29.48 /

+4.52 (+18.11%)

04/24/20 SunTrust
Cloudflare cut to Hold at SunTrust on valuation
04/24/20 SunTrust
Cloudflare downgraded to Hold from Buy at SunTrust
04/14/20 Morgan Stanley
Cloudflare downgraded to Underweight following outperformance at Morgan Stanley
04/14/20 Morgan Stanley
Cloudflare downgraded to Underweight from Equal Weight at Morgan Stanley
HEAR Turtle Beach
$11.48 /

+1.18 (+11.46%)

04/29/20 Wedbush
Turtle Beach downgraded to Neutral at Wedbush as likely upside priced in
04/29/20 Wedbush
Turtle Beach downgraded to Neutral from Outperform at Wedbush
03/11/20 Oppenheimer
Turtle Beach price target lowered to $13 from $18 at Oppenheimer
02/13/20 Lake Street
Turtle Beach price target lowered to $12 from $17 at Lake Street
TRUE TrueCar
$3.34 /

+0.34 (+11.33%)

03/13/20 Stephens
Stephens still sees 'decent chance' of TrueCar being acquired
02/21/20 Craig-Hallum
TrueCar price target lowered to $4 from $5 at Craig-Hallum
02/21/20 Stephens
TrueCar loss of USAA likely to drives shares toward $2, says Stephens
09/12/19
Fly Intel: Top five analyst initiations
ARWR Arrowhead
$35.15 /

+0.98 (+2.87%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
SVMK SurveyMonkey
$17.02 /

+1.11 (+6.98%)

01/17/20 Wells Fargo
SurveyMonkey price target raised to $21 from $18 at Wells Fargo
12/27/19 Stephens
Fiserv, SurveyMonkey among stocks dropped from Stephens Best Ideas list
12/17/19 JMP Securities
SurveyMonkey pricing highlights growing Audience adoption, says JMP Securities
10/15/19 Craig-Hallum
SurveyMonkey initiated with a Buy at Craig-Hallum
GLUU Glu Mobile
$8.94 /

+0.21 (+2.41%)

04/17/20 SunTrust
SciPlay upgraded to Buy at SunTrust as a 'stay-at-home play'
04/13/20 Cowen
Glu Mobile weakness a buying opportunity, says Cowen
04/08/20 Roth Capital
Glu Mobile weakness a buying opportunity, says Roth Capital
04/08/20 Stephens
Glu Mobile downgraded to Underweight from Equal Weight at Stephens
DBX Dropbox
$21.90 /

+1.55 (+7.62%)

03/26/20 Goldman Sachs
Dropbox downgraded to Sell from Neutral at Goldman Sachs
02/21/20 Canaccord
Dropbox results solid but momentum hard to break, says Canaccord
02/21/20 Deutsche Bank
Dropbox target raised to $30 on 'thesis-changing' Q4 at Deutsche Bank
02/21/20 Jefferies
Dropbox price target raised to $21 from $19 at Jefferies
SAIL SailPoint
$19.84 /

+0.82 (+4.31%)

05/04/20 Needham
SailPoint downgraded to Hold from Buy at Needham
04/09/20 DA Davidson
SailPoint upgraded to Buy from Neutral at DA Davidson
04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
UBER Uber
$30.90 /

+3.06 (+10.99%)

05/07/20 Morgan Stanley
Lyft price target raised to $34 from $31 at Morgan Stanley
05/01/20 Citi
Lyft coverage resumed with a Buy at Citi
04/28/20 KeyBanc
KeyBanc says channel work points to Shake Shack reopening ordering system
04/21/20 Guggenheim
Guggenheim raises two auto parts retailers, cuts one supplier in sector shake-up
GPRO GoPro
$3.35 /

+0.105 (+3.24%)

04/21/20 Raymond James
Sonos Radio could drive 'meaningfully higher' multiples, says Raymond James
03/16/20 Citi
GoPro downgraded to Sell from Neutral at Citi
10/03/19 Citi
GoPro investors will view production delay as a negative, says Citi
10/03/19 Morgan Stanley
GoPro price target lowered to $4.50 at Morgan Stanley after HERO8 delay
XNCR Xencor
$30.04 /

-0.95 (-3.07%)

03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Barclays
Xencor initiated with an Underweight at Barclays
02/25/20 Guggenheim
Xencor upgraded to Buy from Neutral at Guggenheim
01/30/20 RBC Capital
Xencor initiated with an Outperform at RBC Capital
KTOS Kratos Defense
$14.98 /

+0.12 (+0.81%)

04/06/20 Canaccord
Kratos Defense acquisition provides long-term opportunity, says Canaccord
03/18/20 Benchmark
Benchmark starts Kratos Defense at Buy, sees 'commanding' lead in drones
03/18/20 Benchmark
Kratos Defense initiated with a Buy at Benchmark
03/11/20 SunTrust
Kratos Defense upgraded to Buy from Hold at SunTrust
GH Guardant Health
$84.06 /

+3.06 (+3.78%)

04/23/20 SVB Leerink
Guardant Health price target lowered to $125 from $130 at SVB Leerink
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
02/21/20
Fly Intel: Top five analyst initiations
02/21/20 Guggenheim
Guggenheim starts Guardant Health at Buy with addressable market seen expanding
IPHI Inphi
$98.85 /

+2.46 (+2.55%)

05/05/20 B. Riley FBR
Inphi price target raised to $86 from $74 at B. Riley FBR
04/23/20 JPMorgan
Inphi price target raised to $120 from $95 at JPMorgan
04/22/20 Craig-Hallum
Inphi price target raised to $120 from $100 at Craig-Hallum
04/22/20 Deutsche Bank
Inphi price target raised to $108 from $90 at Deutsche Bank
AAXN Axon
$70.25 /

+4.14 (+6.26%)

03/02/20 Imperial Capital
Axon downgraded to In-Line from Outperform at Imperial Capital
02/28/20 Needham
Axon price target raised to $90 from $80 at Needham
02/24/20 JPMorgan
Axon price target raised to $92 from $78 at JPMorgan
02/24/20 JPMorgan
Axon price target raised to $92 from $78 at JPMorgan
SPWR SunPower
$7.26 /

-0.25 (-3.33%)

04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
04/03/20 Barclays
Barclays halves SunPower target to $2.50, sees risk of insolvency
03/03/20 Barclays
Sunrun price target raised to $26 from $21 at Barclays
02/13/20 Roth Capital
Roth Capital stays Neutral on SunPower after mixed quarter
SKYW SkyWest
$24.05 /

+0.03 (+0.12%)

04/21/20 Deutsche Bank
SkyWest price target lowered to $47 from $60 at Deutsche Bank
03/23/20 Raymond James
SkyWest price target lowered to $40 from $75 at Raymond James
03/16/20 Goldman Sachs
SkyWest upgraded to Buy from Neutral at Goldman Sachs
03/12/20 Argus
SkyWest upgraded to Buy from Hold at Argus
HLF Herbalife Nutrition
$36.93 /

+3.12 (+9.23%)

12/04/19 Citi
Herbalife Nutrition assumed with a Buy at Citi
10/30/19 Stifel
Nu Skin upgraded to Hold on 'less bad' China expectations at Stifel
08/02/19 Citi
Herbalife Nutrition price target lowered to $57 from $66 at Citi
08/02/19 Pivotal Research
Herbalife Nutrition price target lowered to $65 from $75 at Pivotal Research
PAR Par Technology
$19.73 /

+1 (+5.34%)

05/01/20 Jefferies
Par Technology price target lowered to $25 from $35 at Jefferies
04/05/20 Jefferies
COVID-19 'a tailwind' for restaurant software, Par to take share, says Jefferies
04/03/20 Roth Capital
Par Technology assumed with a Neutral at Roth Capital
03/13/20 Sidoti
Par Technology upgraded to Buy from Neutral at Sidoti
CWH Camping World
$10.77 /

+0.39 (+3.76%)

04/27/20 BMO Capital
Camping World price target lowered to $8.50 from $12 at BMO Capital
04/08/20 Northcoast
Thor Industries, Camping World downgraded at Northcoast after RV industry checks
04/08/20 Northcoast
Camping World downgraded to Neutral from Buy at Northcoast
01/14/20 Northcoast
Camping World upgraded to Buy from Neutral at Northcoast
Hot Stocks
Arrowhead discloses COVID-19 development program » 16:31
05/07/20
05/07
16:31
05/07/20
16:31
ARWR

Arrowhead

$35.12 /

+0.95 (+2.78%)

As part of its Q2…

As part of its Q2 announcement, Arrowhead disclosed that it has :"started a development program to address the current novel coronavirus that causes COVID-19 and other possible future pulmonary-borne pathogens. No additional details about this program are being disclosed at this time."

ShowHide Related Items >><<
ARWR Arrowhead
$35.12 /

+0.95 (+2.78%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
Earnings
Arrowhead reports Q2 EPS (20c), consensus (11c) » 16:06
05/07/20
05/07
16:06
05/07/20
16:06
ARWR

Arrowhead

$35.23 /

+1.06 (+3.10%)

Reports Q2 revenue…

Reports Q2 revenue $23.6M, consensus $21.74M.

ShowHide Related Items >><<
ARWR Arrowhead
$35.23 /

+1.06 (+3.10%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
Hot Stocks
Arrowhead COO Bruce Given retires » 16:02
05/01/20
05/01
16:02
05/01/20
16:02
ARWR

Arrowhead

$32.29 /

-2.19 (-6.35%)

Arrowhead announced the…

Arrowhead announced the retirement of Bruce Given, Arrowhead's COO and head of R&D, which was previously planned and disclosed, after a more than 30-year career in biotechnology and pharmaceutical research, development, and sales and marketing. Given's areas of responsibility have been assumed by Javier San Martin, chief medical officer, Curt Bradshaw, chief scientific officer and James Hassard, chief commercial officer. Given will be retained in an advisory capacity for a period of at least one year.

ShowHide Related Items >><<
ARWR Arrowhead
$32.29 /

-2.19 (-6.35%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
Conference/Events
Jefferies biotech analyst to hold an analyst/industry conference call » 09:25
04/29/20
04/29
09:25
04/29/20
09:25
ARWR

Arrowhead

$37.18 /

-2.29 (-5.80%)

, ALNY

Alnylam

$137.26 /

-5.3 (-3.72%)

, DRNA

Dicerna

$21.10 /

-0.9 (-4.09%)

, VRTX

Vertex

$257.10 /

-11.27 (-4.20%)

Biotech Analyst Raycroft,…

Biotech Analyst Raycroft, along with Dr. Kyle Hogarth of the Alpha One Antitrypsin Deficiency Clinical Resource Center at the University of Chicago, discuss the current state of A1ATD therapies in development on an Analyst/Industry conference call to be held on April 29 at 10 am.

ShowHide Related Items >><<
ARWR Arrowhead
$37.18 /

-2.29 (-5.80%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
ALNY Alnylam
$137.26 /

-5.3 (-3.72%)

04/24/20 Evercore ISI
Alnylam assumed with an Outperform at Evercore ISI
04/14/20 Cantor Fitzgerald
Alnylam price target raised to $202 from $195 at Cantor Fitzgerald
04/14/20 Nomura Instinet
Alnylam risks not absolved with Blackstone deal, says Nomura Instinet
04/13/20 Piper Sandler
Alnylam price target lowered to $142 from $147 at Piper Sandler
DRNA Dicerna
$21.10 /

-0.9 (-4.09%)

04/07/20 H.C. Wainwright
Deal terms show Dicerna has 'upper hand,' says H.C. Wainwright
04/06/20 Piper Sandler
Alnylam collaboration for AATD favors Dicerna, says Piper Sandler
03/19/20
Fly Intel: Top five analyst initiations
03/19/20 Berenberg
Dicerna initiated with a Buy at Berenberg
VRTX Vertex
$257.10 /

-11.27 (-4.20%)

04/28/20
RBC Capital downgraded Vertex to Sector Perform on valuation
04/28/20 RBC Capital
Vertex downgraded to Sector Perform from Outperform at RBC Capital
04/27/20 Piper Sandler
Piper backs Overweight on Vertex after new Affinia partnership
03/27/20 Piper Sandler
Vertex's 2020 business outlook not impacted by COVID-19, says Piper Sandler
Conference/Events
Jefferies biotech analyst to hold an analyst/industry conference call » 04:55
04/29/20
04/29
04:55
04/29/20
04:55
ARWR

Arrowhead

$37.18 /

-2.29 (-5.80%)

, ALNY

Alnylam

$137.26 /

-5.3 (-3.72%)

, DRNA

Dicerna

$21.10 /

-0.9 (-4.09%)

, VRTX

Vertex

$257.10 /

-11.27 (-4.20%)

Biotech Analyst Raycroft,…

Biotech Analyst Raycroft, along with Dr. Kyle Hogarth of the Alpha One Antitrypsin Deficiency Clinical Resource Center at the University of Chicago, discuss the current state of A1ATD therapies in development on an Analyst/Industry conference call to be held on April 29 at 10 am.

ShowHide Related Items >><<
ARWR Arrowhead
$37.18 /

-2.29 (-5.80%)

04/15/20 Cantor Fitzgerald
Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald
04/15/20 Cantor Fitzgerald
Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform from Underperform at SVB Leerink
ALNY Alnylam
$137.26 /

-5.3 (-3.72%)

04/24/20 Evercore ISI
Alnylam assumed with an Outperform at Evercore ISI
04/14/20 Cantor Fitzgerald
Alnylam price target raised to $202 from $195 at Cantor Fitzgerald
04/14/20 Nomura Instinet
Alnylam risks not absolved with Blackstone deal, says Nomura Instinet
04/13/20 Piper Sandler
Alnylam price target lowered to $142 from $147 at Piper Sandler
DRNA Dicerna
$21.10 /

-0.9 (-4.09%)

04/07/20 H.C. Wainwright
Deal terms show Dicerna has 'upper hand,' says H.C. Wainwright
04/06/20 Piper Sandler
Alnylam collaboration for AATD favors Dicerna, says Piper Sandler
03/19/20
Fly Intel: Top five analyst initiations
03/19/20 Berenberg
Dicerna initiated with a Buy at Berenberg
VRTX Vertex
$257.10 /

-11.27 (-4.20%)

04/28/20
RBC Capital downgraded Vertex to Sector Perform on valuation
04/28/20 RBC Capital
Vertex downgraded to Sector Perform from Outperform at RBC Capital
04/27/20 Piper Sandler
Piper backs Overweight on Vertex after new Affinia partnership
03/27/20 Piper Sandler
Vertex's 2020 business outlook not impacted by COVID-19, says Piper Sandler

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.